Home Picking the perfect API partner post pandemic
2022

Picking the perfect API partner post pandemic

by cyb2025
T. Wilson
active pharmaceutical ingredient
API
APIs
supply chain
supply chain partner

TOM WILSON
Global Business Development Lead, Pfizer CentreOne , Collegeville, Pennsylvania, USA

ABSTRACT

Ever tried to bake a cake without key ingredients? The outcomes are sure to be negative. In this piece, Pfizer CentreOne’s Tom Wilson builds on that analogy as it relates to pharma’s manufacturing and business models and the effects of disruptions in the supply of active pharmaceutical ingredients (APIs). The industry’s goal is straightforward: get medicine to patients. If the supply chain is broken, critical medicine’s API supply is disrupted, and that essential promise can be broken.

PICKING THE PERFECT API PARTNER FOR AN IMPERFECT WORLD
Ever tried to bake a cake and realized you don’t have sugar? The outcomes are sure to be negative: frustration, anxiety, and likely plenty of disappointed cake lovers. Although simplistic, the analogy holds true as it relates to pharma’s manufacturing and business models and the effects of disruptions in the supply of active pharmaceutical ingredients (APIs). The industry’s goal is straightforward: get medicine to patients.

 

Pharma is asking its API suppliers to supply API, on time, on target and ready for patients. When a critical medicine’s API supply is disrupted, if not rectified quickly, the consequences for healthcare and patient outcomes can quickly escalate.

 

ABOUT THE AUTHOR

Tom Wilson is the Global Business Development Lead for Pfizer CentreOne. In this role, he serves as the business lead for Custom API, High Potency Oral Solid Dose and Sterile Injectable service offerings. He was formerly Vice President of Contract Manufacturing Operations Pfizer CentreOne Contract Manufacturing serving as manufacturing liaison between the Pfizer Global Supply and Pfizer CentreOne organizations.
Tom is a former United States Air Force Captain, and holds a B.S. in Physics and an M.S. in Administration and Management.

Latest issue

September / October 2025

View Issue

Archive

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt!

Chemistry Today - Archive
Go to archive

Content from magazine

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores.
View all content

The most read

@2019 - All Right Reserved. Designed and Developed by PenciDesign

Login